Mark Kotter, University of Cambridge

Sure, Bit Bio got some sig­nif­i­cant cash for its cell cod­ing work. But it’s the in­sid­ers who are back­ing them that will gar­ner the at­ten­tion

Mark Kot­ter’s syn­thet­ic bi­ol­o­gy team at Bit Bio has al­ready won lots of lo­cal recog­ni­tion in the UK for its tech for pre­ci­sion re­pro­gram­ming of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.